Liverpool alliance expands Eisai's neglected disease interests
This article was originally published in Scrip
Executive Summary
The major Japanese firm Eisai is to work with the Liverpool School of Tropical Medicine (LSTM) and the University of Liverpool in the UK to identify new drugs against two types of the nematode worm parasitic disease, filariasis, which together affect more than 150m people worldwide.